mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.54 |
0.05 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |